Fifty-one Kaposi sarcoma patients

Clinical and Translational Oncology

Volumn 12, Issue 9, 2010, Pages 629-633

  Dogan, Mutlu ^a   Dogan, Lutfi ^b   Ozdemir, Feyyaz ^c   Yildirim Ozdemir, Nuriye ^d   Senol Coskun, Hasan ^e   Yalcintas Arslan, Ulku ^b   Ozal, Guze ^a   Utkan, Gungor ^a   Demirkazik, Ahmet ^a   Aydin, Fazil ^c   Zengin, Nurullah ^d   Icli, Fikri ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chemotherapy in Kaposi sarcoma; Interferon in Kaposi sarcoma; Kaposi sarcoma; Treatment of Kaposi sarcoma

Indexed keywords

BLEOMYCIN; DOXORUBICIN; ETOPOSIDE; INTERFERON; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER SURGERY; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SMOKING; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; FEMALE; HERPESVIRUS 8, HUMAN; HIV SEROPOSITIVITY; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-12; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 77958172308     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0568-7     Document Type: Article

References (24)

1. H.W. Wang M.W. Trotter D. Lagos, et al. 2004 Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma Nat Genet 36 693 (Pubitemid 38886628)
2. U.R. Hengge T. Ruzicka S.K. Tyring, et al. 2002 Update on Kaposi sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy Lancet Infect Dis 2 281 292 10.1016/S1473-3099(02)00263-3 12062994 (Pubitemid 34464739)
3. M. Dubina G. Goldenberg 2009 Viral-associated nonmelanoma skin cancers: a review Am J Dermatopathol 31 561 573 10.1097/DAD.0b013e3181a58234 19590418
4. Y. Chang E. Cesarman M.S. Pessin, et al. 1994 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi sarcoma Science 266 1865 1869 1:CAS:528:DyaK2MXislCjs78%3D 10.1126/science.7997879 7997879
5. L. Strichman-Almashanau S. Weltfriend O. Gideoni 1995 No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients J Clin Immunol 15 205 209 10.1007/BF01541091
6. D.L. Mann C. Murray M. O'Donnell 1990 HLA antigen frequencies in HIV-1-related Kaposi sarcoma J Acquir Immune Defic Synd 3 51 55 (Pubitemid 20317571)
7. M.R. Hussein 2008 Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi sarcoma Cell Biol Int 32 157 162 1:CAS:528: DC%2BD1cXitlKitr4%3D 10.1016/j.cellbi.2007.08.021 17950633 (Pubitemid 351249148)
8. M.C. Nascimento V.A. de Souza L.M. Sumita, et al. 2008 Prevalence of, and Risk Factors for Kaposi Sarcoma-Associated Herpesvirus Infection Among Blood Donors in Brazil: A Multi-Center Serosurvey J Med Virology 80 1202 1210 10.1002/jmv.21188 (Pubitemid 351705999)
9. N. Crum-Cianflone K.H. Hullsiek E. Satter, et al. 2009 Cutaneous malignancies among HIV-infected persons Arch Intern Med 169 1130 1138 10.1001/archinternmed.2009.104 19546414
10. Wen KW, Damania B (2009) Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett doi: 10.1016/j.canlet.2009.07.004
11. P. Ahmadpoor 2009 Human herpes virus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis Iran J Kidney Dis 3 121 126 19617659
12. P. Piselli G. Busnach F. Citterio, et al. 2009 Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006 Transplant Proc 41 1227 1230 1:STN:280:DC%2BD1MzmtFajsw%3D%3D 10.1016/j.transproceed.2009.03.009 19460525
13. L.J. Conley T.J. Bush S.P. Buchbinder 1996 The association between cigarette smoking and selected HIV-related medical conditions AIDS 10 1121 1126 1:STN:280:DyaK2s%2FivVKitA%3D%3D 8874629
14. R.A. Schwartz 2004 Kaposi sarcoma: an update J Surg Oncol 87 146 151 10.1002/jso.20090 15334644 (Pubitemid 39167396)
15. A. Kapoor 2008 Malignancy in kidney transplant recipients Drugs 68 11 19 1:CAS:528:DC%2BD1cXmtFOjsrg%3D 10.2165/00003495-200868001-00003 18442297 (Pubitemid 351601433)
16. S.E. Krown D.W. Northfelt D. Osoba J.S. Stewart 2004 Use of liposomal anthracyclines in Kaposi sarcoma Semin Oncol 31 36 52 1:CAS:528: DC%2BD2MXhtVyns7Y%3D 10.1053/j.seminoncol.2004.08.003 15717737 (Pubitemid 40023241)
17. U.R. Hengge S. Esser H.P. Rudel M. Goos 2001 Long-term chemotherapy of HIV-associated Kaposi sarcoma with liposomal doxorubicin Eur J Cancer 37 878 883 1:CAS:528:DC%2BD3MXislGhtbo%3D 10.1016/S0959-8049(01)00053-3 11313176 (Pubitemid 32323966)
18. L. Brambilla A. Romanelli M. Bellinvia 2008 Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases Br J Dermatol 158 1339 1344 1:STN:280:DC%2BD1czhvVKitA%3D%3D 10.1111/j.1365-2133.2008.08517.x 18363766 (Pubitemid 351692862)
19. Ramirez-Rodriguez JM, Morgan-Villela G, Robles-Toscano JA, Echeagaray E (1996) Therapeutic response of the epidemic Kaposi Sarcoma. Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 212 (abstract I142)
20. N. Silvestris D. Galeta G. Colucci 2009 Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi sarcoma Anticancer Res 29 675 676 1:CAS:528:DC%2BD1MXjs12ru7o%3D 19331220
21. L. Fardet P.E. Stoebner H. Bachelez, et al. 2006 Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection Cancer 106 1785 1789 1:CAS:528: DC%2BD28XksFCrsrs%3D 10.1002/cncr.21791 16534786
22. R.J. Sullivan L. Pantanowitz B.J. Dezube 2009 Targeted therapy for Kaposi sarcoma BioDrugs 23 6975 10.2165/00063030-200923020-00001
23. A.M. Berson J.M. Quivey J.W. Harris W.M. Wara 1990 Radiation therapy for AIDS-related Kaposi sarcoma Int J Radiat Oncol Biol Phys 19 569 575 1:STN:280:DyaK3M%2FgvVCrug%3D%3D 2211205
24. S. Basciani R. Vona P. Matarrese, et al. 2007 Imatinib interferes with survival of multidrug resistant Kaposi sarcoma cells FEBS Lett 581 5897 5903 1:CAS:528:DC%2BD2sXhsVCgsr7F 10.1016/j.febslet.2007.11.069 18061581 (Pubitemid 50009360)